Is MEDI - LINE still active?

Yes, MEDI - LINE is currently active.

Where is MEDI - LINE registered?

MEDI - LINE's registered address is Rue des Gardes-frontière 5, 4031 Liège, Belgium.

How many employees does MEDI - LINE have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), MEDI - LINE reported 56.6 full-time equivalent employees.

What is MEDI - LINE's annual turnover?

MEDI - LINE's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €10,864,968.

Did MEDI - LINE make a profit or a loss?

MEDI - LINE's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €293,181.

When did MEDI - LINE last file annual accounts?

MEDI - LINE's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is MEDI - LINE B Corp certified?

We have no B Corp certification on file for MEDI - LINE.

Does MEDI - LINE hold Fairtrade certification?

No, MEDI - LINE does not currently hold Fairtrade certification.

MEDI - LINE

Q: When was MEDI - LINE founded?

MEDI - LINE was founded on 18 Feb 1994, making it 32 years old.

Q: What does MEDI - LINE do?

MEDI - LINE's registered main activities are Manufacture of other pharmaceutical products, Manufacture of medical and dental instruments and supplies, Manufacture of medical, surgical, dental or veterinary furniture: operating tables, hospital beds with mechanical fittings, dentists chairs, and Wholesale trade of medical, surgical and dental supplies.

BE 0452.084.633

Copied!

NV/SA

Status

Active

Founded

18 Feb 1994

Size

Medium · 56.6 FTE

Age

32 yrs

Main activity

Manufacture of other pharmaceutical products

Activities

4 activities

Manufacture of other pharmaceutical productsManufacture of medical and dental instruments and suppliesManufacture of medical, surgical, dental or veterinary furniture: operating tables, hospital beds with mechanical fittings, dentists chairsWholesale trade of medical, surgical and dental supplies

Financials

Turnover2025

€10.9M+2.5%

Profit / Loss2025

€293K+0.7%

Equity2025

€3.8M+23.6%

2025	2024	2023	2022
€10,864,968+2.5%	€10,604,713	—	—
€293,181+0.7%	€291,280-68.2%	€915,471+116.7%	€422,543
€3,777,693+23.6%	€3,056,823+9%	€2,804,990+47%	€1,907,783
€5,085,306-6.9%	€5,460,766+56.5%	€3,488,980+6%	€3,291,204
€241,054+281.8%	€63,137-90%	€631,455+159.2%	€243,637
56.6+8%	52.4+1.2%	51.8-4.8%	54.4
€191,961-5.1%	€202,380	—	—

Frequently asked questions

01What is MEDI - LINE's official registered name?

MEDI - LINE.

02What is MEDI - LINE's enterprise number (VAT number)?

BE 0452.084.633.

03What is MEDI - LINE's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was MEDI - LINE founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	€10,864,968+2.5%	€10,604,713	—	—
	56.6+8%	52.4+1.2%	51.8-4.8%	54.4
	€191,961-5.1%	€202,380	—	—
	—	—	€4,625,415+33.3%	€3,468,841
	€3,477,277+14.8%	€3,028,287+1.1%	€2,995,132+11.6%	€2,683,655
	—	—	€1,045,053>1000%	€87,607
	€476,167-13.1%	€547,978-58.1%	€1,307,217+123.4%	€585,053
	€789,604+15.6%	€683,108-57.2%	€1,595,875+108.3%	€766,302
	—	—	—	€593,792
	€293,181+0.7%	€291,280-68.2%	€915,471+116.7%	€422,543
	€105,957+34.4%	€78,831-32.3%	€116,511+12.2%	€103,818
Profitability
	7.3%+12.8%	6.4%	—	—
	2.7%-1.8%	2.7%	—	—
	7.8%-18.5%	9.5%-70.8%	32.6%+47.4%	22.1%
	3.3%-3.2%	3.4%-76.4%	14.5%+79.3%	8.1%
Solvency
	€8,875,884+4%	€8,535,291+35.1%	€6,316,487+20.9%	€5,226,320
	€3,162,917-4.2%	€3,300,521+103.6%	€1,621,269+112.8%	€762,004
	€1020%	€1020%	€1020%	€102
	€3,777,693+23.6%	€3,056,823+9%	€2,804,990+47%	€1,907,783
	42.6%+18.8%	35.8%-19.3%	44.4%+21.7%	36.5%
	€1,915,861-10.5%	€2,140,230+149.6%	€857,541+43.4%	€598,143
	0.51-27.6%	0.70+129%	0.31-2.5%	0.31
	€5,085,306-6.9%	€5,460,766+56.5%	€3,488,980+6%	€3,291,204
	1.35-24.6%	1.79+43.6%	1.24-27.9%	1.73
	3.36-9.3%	3.71	—	—
Liquidity
	€241,054+281.8%	€63,137-90%	€631,455+159.2%	€243,637
	€2,611,818-1.9%	€2,661,927+17.7%	€2,262,571-7.3%	€2,441,883
	€2,242,072-2%	€2,287,316+42.3%	€1,607,089-1.1%	€1,625,357
	€1,147,749-0.1%	€1,149,128-23.5%	€1,502,141+11.8%	€1,343,066
	€3,163,611-4.5%	€3,314,265+26%	€2,631,439+2.3%	€2,572,709
	1.72+11%	1.55+0.8%	1.54-1.4%	1.56
	€2,533,638+33.3%	€1,900,275-7.6%	€2,056,414+16.6%	€1,762,975
Efficiency
	75 days-4.3%	79 days	—	—
	61 days-0.9%	61 days	—	—
	214 days-12.3%	244 days	—	—
	1.69+4.3%	1.62	—	—
Profit appropriation
	—	€25,000	—	—
	€1,753,410+10.3%	€1,589,2200%	€1,589,220+43.8%	€1,105,070
	€1,481,489+9.5%	€1,352,498+24.5%	€1,086,218+65.9%	€654,896

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€10,864,968+2.5%	€10,604,713	—	—
	56.6+8%	52.4+1.2%	51.8-4.8%	54.4
	€191,961-5.1%	€202,380	—	—
	—	—	€4,625,415+33.3%	€3,468,841
	€3,477,277+14.8%	€3,028,287+1.1%	€2,995,132+11.6%	€2,683,655
	—	—	€1,045,053>1000%	€87,607
	€476,167-13.1%	€547,978-58.1%	€1,307,217+123.4%	€585,053
	€789,604+15.6%	€683,108-57.2%	€1,595,875+108.3%	€766,302
	—	—	—	€593,792
	€293,181+0.7%	€291,280-68.2%	€915,471+116.7%	€422,543
	€105,957+34.4%	€78,831-32.3%	€116,511+12.2%	€103,818
Profitability
	7.3%+12.8%	6.4%	—	—
	2.7%-1.8%	2.7%	—	—
	7.8%-18.5%	9.5%-70.8%	32.6%+47.4%	22.1%
	3.3%-3.2%	3.4%-76.4%	14.5%+79.3%	8.1%
Solvency
	€8,875,884+4%	€8,535,291+35.1%	€6,316,487+20.9%	€5,226,320
	€3,162,917-4.2%	€3,300,521+103.6%	€1,621,269+112.8%	€762,004
	€1020%	€1020%	€1020%	€102
	€3,777,693+23.6%	€3,056,823+9%	€2,804,990+47%	€1,907,783
	42.6%+18.8%	35.8%-19.3%	44.4%+21.7%	36.5%
	€1,915,861-10.5%	€2,140,230+149.6%	€857,541+43.4%	€598,143
	0.51-27.6%	0.70+129%	0.31-2.5%	0.31
	€5,085,306-6.9%	€5,460,766+56.5%	€3,488,980+6%	€3,291,204
	1.35-24.6%	1.79+43.6%	1.24-27.9%	1.73
	3.36-9.3%	3.71	—	—
Liquidity
	€241,054+281.8%	€63,137-90%	€631,455+159.2%	€243,637
	€2,611,818-1.9%	€2,661,927+17.7%	€2,262,571-7.3%	€2,441,883
	€2,242,072-2%	€2,287,316+42.3%	€1,607,089-1.1%	€1,625,357
	€1,147,749-0.1%	€1,149,128-23.5%	€1,502,141+11.8%	€1,343,066
	€3,163,611-4.5%	€3,314,265+26%	€2,631,439+2.3%	€2,572,709
	1.72+11%	1.55+0.8%	1.54-1.4%	1.56
	€2,533,638+33.3%	€1,900,275-7.6%	€2,056,414+16.6%	€1,762,975
Efficiency
	75 days-4.3%	79 days	—	—
	61 days-0.9%	61 days	—	—
	214 days-12.3%	244 days	—	—
	1.69+4.3%	1.62	—	—
Profit appropriation
	—	€25,000	—	—
	€1,753,410+10.3%	€1,589,2200%	€1,589,220+43.8%	€1,105,070
	€1,481,489+9.5%	€1,352,498+24.5%	€1,086,218+65.9%	€654,896

2025

2024

2023

2022

Income statement

€10,864,968+2.5%

€10,604,713

—

56.6+8%

52.4+1.2%

51.8-4.8%

54.4

€191,961-5.1%

€202,380

—

€4,625,415+33.3%

€3,468,841

€3,477,277+14.8%

€3,028,287+1.1%

€2,995,132+11.6%

€2,683,655

—

€1,045,053>1000%

€87,607

€476,167-13.1%

€547,978-58.1%

€1,307,217+123.4%

€585,053

€789,604+15.6%

€683,108-57.2%

€1,595,875+108.3%

€766,302

—

€593,792

€293,181+0.7%

€291,280-68.2%

€915,471+116.7%

€422,543

€105,957+34.4%

€78,831-32.3%

€116,511+12.2%

€103,818

Profitability

7.3%+12.8%

6.4%

—

2.7%-1.8%

2.7%

—

7.8%-18.5%

9.5%-70.8%

32.6%+47.4%

22.1%

3.3%-3.2%

3.4%-76.4%

14.5%+79.3%

8.1%

Solvency

€8,875,884+4%

€8,535,291+35.1%

€6,316,487+20.9%

€5,226,320

€3,162,917-4.2%

€3,300,521+103.6%

€1,621,269+112.8%

€762,004

€1020%

€102

€3,777,693+23.6%

€3,056,823+9%

€2,804,990+47%

€1,907,783

42.6%+18.8%

35.8%-19.3%

44.4%+21.7%

36.5%

€1,915,861-10.5%

€2,140,230+149.6%

€857,541+43.4%

€598,143

0.51-27.6%

0.70+129%

0.31-2.5%

0.31

€5,085,306-6.9%

€5,460,766+56.5%

€3,488,980+6%

€3,291,204

1.35-24.6%

1.79+43.6%

1.24-27.9%

1.73

3.36-9.3%

3.71

—

Liquidity

€241,054+281.8%

€63,137-90%

€631,455+159.2%

€243,637

€2,611,818-1.9%

€2,661,927+17.7%

€2,262,571-7.3%

€2,441,883

€2,242,072-2%

€2,287,316+42.3%

€1,607,089-1.1%

€1,625,357

€1,147,749-0.1%

€1,149,128-23.5%

€1,502,141+11.8%

€1,343,066

€3,163,611-4.5%

€3,314,265+26%

€2,631,439+2.3%

€2,572,709

1.72+11%

1.55+0.8%

1.54-1.4%

1.56

€2,533,638+33.3%

€1,900,275-7.6%

€2,056,414+16.6%

€1,762,975

Efficiency

75 days-4.3%

79 days

—

61 days-0.9%

61 days

—

214 days-12.3%

244 days

—

1.69+4.3%

1.62

—

Profit appropriation

—

€25,000

—

€1,753,410+10.3%

€1,589,2200%

€1,589,220+43.8%

€1,105,070

€1,481,489+9.5%

€1,352,498+24.5%

€1,086,218+65.9%

€654,896

MEDI - LINE

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements